• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于雄激素受体的手性非甾体亲和配体。1. B芳香环带有亲电基团的比卡鲁胺类似物。

Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring.

作者信息

Kirkovsky L, Mukherjee A, Yin D, Dalton J T, Miller D D

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee-Memphis, Memphis, Tennessee 38163, USA.

出版信息

J Med Chem. 2000 Feb 24;43(4):581-90. doi: 10.1021/jm990027x.

DOI:10.1021/jm990027x
PMID:10691684
Abstract

A series of chiral analogues of bicalutamide bearing electrophilic groups (isothiocyanate, N-chloroacetyl, and N-bromoacetyl) on aromatic ring B of the parent molecule were synthesized. These compounds were designed as affinity ligands for the androgen receptor (AR). We prepared the (R)- and (S)-optical isomers of these compounds as pure enantiomers. The AR binding affinities of these compounds were measured in a competitive binding assay with the radiolabeled high-affinity AR ligand, [(3)H]mibolerone. In accordance with our previous results for the enantiomers of bicalutamide, we found that all (R)-isomers demonstrated much higher binding affinity to the AR as compared to their corresponding (S)-isomers. The para-substituted affinity ligands in ring B bound the AR with higher affinities than the corresponding meta-substituted analogues. Oxidation of thioester affinity ligands to their sulfonyl analogues for the para-substituted compounds decreased AR binding affinities and similar modification increased binding affinities for corresponding meta-analogues. The least potent para-substituted sulfonyl compounds had higher AR binding affinities than the most potent meta-substituted sulfonyl compounds. Overall, the para-substituted unoxidized molecules demonstrated the highest AR binding affinity. Subsequent research using AR exchange assays and Scatchard analyses showed that the isothiocyanate affinity ligands (R)-7, (R)-9, and (R)-10 reported herein are the first specific chemoaffinity ligands for the AR.

摘要

合成了一系列比卡鲁胺的手性类似物,这些类似物在母体分子的芳环B上带有亲电基团(异硫氰酸酯、N - 氯乙酰基和N - 溴乙酰基)。这些化合物被设计为雄激素受体(AR)的亲和配体。我们制备了这些化合物的(R) - 和(S) - 光学异构体作为纯对映体。在与放射性标记的高亲和力AR配体[(³)H]米勃酮的竞争性结合试验中测量了这些化合物的AR结合亲和力。与我们之前对比卡鲁胺对映体的研究结果一致,我们发现所有(R) - 异构体与其相应的(S) - 异构体相比,对AR表现出更高的结合亲和力。芳环B上的对位取代亲和配体与AR结合的亲和力高于相应的间位取代类似物。对于对位取代的化合物,硫酯亲和配体氧化为其磺酰类似物会降低AR结合亲和力,而类似的修饰会增加相应间位类似物的结合亲和力。活性最低的对位取代磺酰化合物的AR结合亲和力高于活性最高的间位取代磺酰化合物。总体而言,未氧化的对位取代分子表现出最高的AR结合亲和力。随后使用AR交换试验和Scatchard分析的研究表明,本文报道的异硫氰酸酯亲和配体(R) - 7、(R) - 9和(R) - 10是AR的首批特异性化学亲和配体。

相似文献

1
Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring.用于雄激素受体的手性非甾体亲和配体。1. B芳香环带有亲电基团的比卡鲁胺类似物。
J Med Chem. 2000 Feb 24;43(4):581-90. doi: 10.1021/jm990027x.
2
Affinity labeling of the androgen receptor with nonsteroidal chemoaffinity ligands.用非甾体化学亲和配体对雄激素受体进行亲和标记。
Biochem Pharmacol. 1999 Oct 15;58(8):1259-67. doi: 10.1016/s0006-2952(99)00218-x.
3
Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor.对雄激素受体具有高结合亲和力和强功能活性的新型非甾体配体。
Eur J Med Chem. 2002 Aug;37(8):619-34. doi: 10.1016/s0223-5234(02)01335-1.
4
Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging.[18F]比卡鲁胺、4-[76Br]溴比卡鲁胺和4-[76Br]溴硫比卡鲁胺作为用于前列腺癌成像的非甾体雄激素的合成及生物学评价
J Med Chem. 2007 Mar 8;50(5):1028-40. doi: 10.1021/jm060847r.
5
Enantioselective binding of Casodex to the androgen receptor.
Xenobiotica. 1996 Feb;26(2):117-22. doi: 10.3109/00498259609046693.
6
Interaction mechanism exploration of R-bicalutamide/S-1 with WT/W741L AR using molecular dynamics simulations.使用分子动力学模拟探索R-比卡鲁胺/S-1与野生型/ W741L雄激素受体的相互作用机制
Mol Biosyst. 2015 Dec;11(12):3347-54. doi: 10.1039/c5mb00499c. Epub 2015 Oct 7.
7
Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.用于雄激素受体结合和激活的非甾体配体的关键结构特征。
Mol Pharmacol. 2003 Jan;63(1):211-23. doi: 10.1124/mol.63.1.211.
8
In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.具有B环多个取代基的新型雄激素受体配体的体外和体内构效关系
Endocrinology. 2005 Dec;146(12):5444-54. doi: 10.1210/en.2005-0732. Epub 2005 Sep 15.
9
Chemical Degradation of Androgen Receptor (AR) Using Bicalutamide Analog-Thalidomide PROTACs.使用比卡鲁胺类似物-沙利度胺PROTACs对雄激素受体(AR)进行化学降解
Molecules. 2021 Apr 26;26(9):2525. doi: 10.3390/molecules26092525.
10
Molecular mechanism of R-bicalutamide switching from androgen receptor antagonist to agonist induced by amino acid mutations using molecular dynamics simulations and free energy calculation.利用分子动力学模拟和自由能计算研究氨基酸突变诱导R-比卡鲁胺从雄激素受体拮抗剂转变为激动剂的分子机制。
J Comput Aided Mol Des. 2016 Dec;30(12):1189-1200. doi: 10.1007/s10822-016-9992-2. Epub 2016 Nov 15.

引用本文的文献

1
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer.代谢制导的选择性雄激素受体拮抗剂:针对恩杂鲁胺耐药前列腺癌的活性的设计、合成和生物学评价。
J Med Chem. 2023 Mar 9;66(5):3372-3392. doi: 10.1021/acs.jmedchem.2c01858. Epub 2023 Feb 24.
2
Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells.抗雄激素金纳米粒子双重靶向并克服激素不敏感前列腺癌细胞的治疗抵抗性。
Bioconjug Chem. 2012 Aug 15;23(8):1507-12. doi: 10.1021/bc300158k. Epub 2012 Jul 12.
3
Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore.
含腈类药物:腈药效基团的有效作用
J Med Chem. 2010 Nov 25;53(22):7902-17. doi: 10.1021/jm100762r. Epub 2010 Aug 30.
4
Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.B环取代模式对丙酰胺选择性雄激素受体调节剂结合模式的影响。
Bioorg Med Chem Lett. 2008 Oct 15;18(20):5567-70. doi: 10.1016/j.bmcl.2008.09.002. Epub 2008 Sep 5.
5
Synthesis of oxazolidinedione derived bicalutamide analogs.恶唑烷二酮衍生的比卡鲁胺类似物的合成。
Tetrahedron Lett. 2006 Jun 5;47(23):3953-3955. doi: 10.1016/j.tetlet.2006.03.146.
6
Synthesis of irreversibly binding bicalutamide analogs for imaging studies.用于成像研究的不可逆结合比卡鲁胺类似物的合成。
Tetrahedron Lett. 2005 Jul 11;46(28):4821-4823. doi: 10.1016/j.tetlet.2005.04.143.
7
Cesium fluoride and tetra-n-butylammonium fluoride mediated 1,4-N-->O shift of disubstituted phenyl ring of a bicalutamide derivative.氟化铯和四丁基氟化铵介导比卡鲁胺衍生物双取代苯环的1,4-氮到氧迁移。
Tetrahedron Lett. 2006 Jun 5;47(23):3941-3944. doi: 10.1016/j.tetlet.2006.03.154.
8
Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer.用于前列腺癌的芳基异硫氰酸酯选择性雄激素受体调节剂(SARMs)。
Bioorg Med Chem. 2006 Oct 1;14(19):6525-38. doi: 10.1016/j.bmc.2006.06.019. Epub 2006 Jul 7.
9
In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.具有B环多个取代基的新型雄激素受体配体的体外和体内构效关系
Endocrinology. 2005 Dec;146(12):5444-54. doi: 10.1210/en.2005-0732. Epub 2005 Sep 15.
10
Discovery and therapeutic promise of selective androgen receptor modulators.选择性雄激素受体调节剂的发现及其治疗前景
Mol Interv. 2005 Jun;5(3):173-88. doi: 10.1124/mi.5.3.7.